Beacon Diagnostics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Beacon Diagnostics Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $1.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Beacon Diagnostics Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $1.9M Trade | TransData Nexus

Beacon Diagnostics Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $1.9M Total Trade · DGFT Verified

Beacon Diagnostics Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.9M across 3 products in 1 therapeutic categories. Based on 1,681 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Diagnostic ($914.1K), Reagent ($906.0K), Instrument ($36.6K).

Beacon Diagnostics Private Limited — Export Portfolio & Destination Treemap

Beacon Diagnostics Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Beacon Diagnostics Private Limited? — Company Overview & Market Position

Beacon Diagnostics Private Limited, established on May 15, 1990, is a privately held Indian company specializing in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is registered under the Corporate Identification Number (CIN) U24232GJ1990PTC013764 and is headquartered at 424, New G.I.D.C. Estate, Kabilpore, Navsari, Gujarat, India.

As of the latest available data, Beacon Diagnostics has an authorized capital of ₹25,00,000 and a paid-up capital of ₹9,12,000. The company employs between 501 to 1000 individuals across various functions, including management, manufacturing, quality control, research and development, administration, and logistics.

Beacon Diagnostics operates under the ownership of its promoters, with a significant majority stake held by them. The company's financial performance has shown resilience, with a net worth increase of 20.01% in 2023, despite a minor drop in revenue and a substantial decrease in profitability during the same period.

What Does Beacon Diagnostics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Diagnostic$914.1K

Product Portfolio — Top 3 by Export Value

Beacon Diagnostics Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diagnostic	Medical Devices & Diagnostics	$914.1K	836	3.8%	7
2	Reagent	Medical Devices & Diagnostics	$906.0K	802	5.2%	3
3	Instrument	Medical Devices & Diagnostics	$36.6K	43	2.7%	9

Beacon Diagnostics Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $1.9M. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Beacon Diagnostics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Beacon Diagnostics boasts a state-of-the-art manufacturing facility spanning over 40,000 square feet in Navsari, Gujarat. This facility is dedicated to the production of diagnostic reagents and medical devices, adhering to stringent quality standards. The plant is equipped with advanced machinery and technology to ensure the efficient and precise manufacturing of its product range.

3Key Leadership

The leadership team at Beacon Diagnostics is spearheaded by Managing Director Dineshchandra Kalidas Joshi, who has been at the helm since the company's inception in 1990. Other key directors include Swati Narendra Shethji, appointed on June 22, 2006, and Chirag Dineshchandra Joshi, who joined the board on April 7, 2015.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Beacon Diagnostics Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Beacon Diagnostics has made significant strides in expanding its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and certifications, such as ISO 9001:2015 and ISO 13485:2016, which are recognized internationally. These certifications underscore Beacon Diagnostics' commitment to maintaining high-quality standards in its manufacturing processes.

2Emerging Markets

In addition to its presence in regulated markets, Beacon Diagnostics has strategically penetrated emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to international quality standards, as evidenced by its ISO certifications, facilitates its entry into these regions. While specific details regarding WHO prequalification are not available, the company's global footprint indicates a proactive approach to meeting international regulatory requirements.

3Geographic Strategy

Beacon Diagnostics demonstrates a diversified geographic strategy by establishing a presence in both regulated and emerging markets. This approach mitigates concentration risk and positions the company to leverage growth opportunities across different regions. The strategic direction reflects a balanced focus on expanding market reach while maintaining compliance with international standards.

Beacon Diagnostics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Beacon Diagnostics' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's adherence to ISO 9001:2015 and ISO 13485:2016 certifications suggests a commitment to quality management systems that align with international standards, potentially facilitating FDA compliance.

2WHO & EU GMP

Beacon Diagnostics holds ISO 9001:2015 and ISO 13485:2016 certifications, which are recognized internationally and align with Good Manufacturing Practice (GMP) standards. While specific WHO prequalification and EU GMP certificates are not explicitly mentioned, the company's commitment to quality is evident through these certifications.

3CDSCO & Indian Regulatory

Beacon Diagnostics operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds the necessary manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Additionally, Beacon Diagnostics has obtained the Import Export Code (IEC) 0891003665, facilitating its export activities.

Beacon Diagnostics Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Beacon Diagnostics operates in a competitive landscape with several key players in the diagnostic reagents and medical devices sector. While specific market share data is not available, the company's extensive product portfolio and international certifications position it favorably in the market. The company's focus on quality and innovation provides a competitive edge in both domestic and international markets.

2Key Differentiators

Beacon Diagnostics' key differentiators include its comprehensive product portfolio, which spans diagnostic reagents and medical devices, and its commitment to quality, as evidenced by ISO 9001:2015 and ISO 13485:2016 certifications. The company's extensive manufacturing facility and dedicated workforce further enhance its ability to meet diverse customer needs.

3Strategic Position

Beacon Diagnostics is strategically positioned as a manufacturer of diagnostic reagents and medical devices, focusing on both domestic and international markets. The company's adherence to international quality standards and its diversified product portfolio reflect a strategic direction aimed at sustainable growth and market expansion.

Buyer Due Diligence Brief — Evaluating Beacon Diagnostics Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Beacon Diagnostics demonstrates a strong track record in manufacturing and exporting diagnostic reagents and medical devices. The company's export volume and consistency are supported by its adherence to international quality standards and certifications. Reliability indicators include its established presence in various international markets and a dedicated workforce committed to quality and customer satisfaction.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

ISO 9001:2015: Quality management systems certification. Verification can be done through the International Organization for Standardization (ISO) website.

ISO 13485:2016: Quality management systems for medical devices certification. Verification can be done through the International Organization for Standardization (ISO) website.

Frequently Asked Questions — Beacon Diagnostics Private Limited

How many pharmaceutical products does Beacon Diagnostics Private Limited export from India?

Beacon Diagnostics Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Diagnostic ($914.1K), Reagent ($906.0K), Instrument ($36.6K). Total export value is $1.9M.

What is Beacon Diagnostics Private Limited's total pharmaceutical export value?

Beacon Diagnostics Private Limited's total pharmaceutical export value is $1.9M, based on 1,681 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Beacon Diagnostics Private Limited cover?

Beacon Diagnostics Private Limited exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 3 products).

Get Full Beacon Diagnostics Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.